Stocks

Participants Liz Morali Morali; President of Investor Relations; Applied Materials Inc Gary Dickerson; President, Chief Executive Officer, Director; Applied Materials Inc Brice Hill; Senior Vice President, Chief Financial Officer and Global Information Services; Applied Materials Inc Stacy Rasgon; Analyst; Bernstein Research Vivek Arya; Analyst; …

In the first three months of the year Tesla reported deliveries of 336,681, a drop of 13% versus a year ago, missing estimates of 390,000 units. It was Tesla’s worst quarter for deliveries since the second quarter of 2022. The concern for Tesla (TSLA) …

Participants Nicole Shevins; Senior Vice President of Investor Relations and Corporate Communications; Take-Two Interactive Software Inc Strauss Zelnick; Executive Chairman of the Board, Chief Executive Officer; Take-Two Interactive Software Inc Karl Slatoff; President; Take-Two Interactive Software Inc Lainie Goldstein; Chief Financial Officer; Take-Two Interactive …

GREENWICH, Conn., May 16, 2025 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (NasdaqGS: OXLCG) (“Oxford Lane,” the “Company,” “we,” “us” or “our”) has been named “Best Public Closed-End CLO Fund” …

Investors were disappointed with the weak earnings posted by Akamai Technologies, Inc. (NASDAQ:AKAM). However, our analysis suggests that the soft headline numbers are getting counterbalanced by some positive underlying factors. Our free stock report includes 2 warning signs investors should be aware of before …

Cronos Group Inc.'s (TSE:CRON) strong earnings report was rewarded with a positive stock price move. Our analysis found some more factors that we think are good for shareholders. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments …

This week, Bayer BAYRY announced first-quarter 2025 results. Novo Nordisk NVO and GSK plc GSK announced licensing deals with smaller biotechs. The FDA granted approval to Merck’s MRK drug, Welireg, for its third indication in the United States and AbbVie’s ABBV Emrelis, its first …